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Background: The role of marketing and industry in the treatment decisions of orthodontists has received
increasing attention in recent years with clinical research typically undertaken subsequent to established use of
these devices and often failing to confirm the promise of manufacturers’ claims. This meta-epidemiological study
was undertaken to assess the proportion of clinical trials in orthodontics evaluating commercially marketed
products and to evaluate the direction of the results of these studies.
Methods: Electronic searching was undertaken to identify randomized controlled trials (RCTs) published over a
5-year period (1 January 2012 to 31 December 2016). Data obtained included the type of marketed intervention,
direction of effect and declaration of both industry sponsorship and conflict of interest.
Results: Eighty-four RCTs published in 23 scientific journals were included with the highest percentage in the American
Journal of Dentofacial Orthopedics (AJO-DO) (23.8%), followed by the European Journal of Orthodontics (EJO) (14.3%),
Journal of Orthodontics (JO) (10.7%) and Angle Orthodontist (AO) (10.7%). Overall, 45% (38/84) of clinical trials assessed
involved analysis of marketed products after their introduction. Interventions to improve oral health or circumvent the risk
of iatrogenic damage, such as white spot lesions, were most commonly assessed (15.8%), with the relative merits of
non-surgical adjuncts (14.1%) and other orthodontic auxiliaries (13.1%) also frequently evaluated. In 44% of RCTs, a
positive effect of the marketed intervention was not reported. Industry sponsorship of the research was declared in 9.5%
RCTs. No significant associations between the direction of the effect and both declaration of industry sponsorship (p= 0.56)
and conflict of interest (p = 0.96) were detected. Moreover, for marketed and non-marketed products, no significant
associations for both declaration of industry sponsorship (p = 0.44) and conflict of interest (p = 0.28) were found.
Conclusions: Almost half of orthodontic clinical trials over the past 5 years involve analysis of marketed products after
their introduction. The results highlight a potential source of waste in orthodontic research emanating from existing
approaches to licensing and marketing of orthodontic products.Background
Engagement of orthodontists with industry and commer-
cial interests is necessary to facilitate the development,
refinement and adoption of novel products. There has,
however, been concerns in recent years that financial
interests have led to vociferous advertisement and early
adoption of relatively untested products, culminating in a
plea that “truth not product should drive progress” in* Correspondence: jadbinder.seehra@nhs.net
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tics with an acceptance that clinical judgments relating to
selection of medical pharmacological agents may be
affected by inducements and financial motives [2, 3].
In order to mitigate the misleading effects of the fevered
promotion of apparently unique products by commercial
interests, clinical decisions should where possible be
evidence-based. Ideally, the latter should be founded upon
patient wishes and professional experience, allied to the as-
surance offered by best available evidence. While dentistry
and orthodontics lagged behind pioneering medical special-
ties, evidence-based orthodontics is now firmly recognized
[4]. In 2015, for example, there were 89 dental journals andis distributed under the terms of the Creative Commons Attribution 4.0
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citable papers published in these orthodontic journals
alone, and the past decade has seen significant increases in
the quantity of systematic reviews in orthodontics with 157
published between 2000 and 2014, although the yield from
many of these has been limited [5].
Within this evidence-based approach, clinical trials which
incorporate random allocation of participants to treatment
groups are considered optimal to allow evaluation of the
comparative effectiveness of interventions. However, clin-
ical trials are expensive to undertake, are time-consuming
and are demanding in terms of evaluation and follow-up.
As such, while the relative frequency of clinical trials has
increased in orthodontics, it is known that systematic re-
views comparing the effectiveness of interventions almost
invariably cite a lack of primary studies, particularly those
of high quality, with a mean of just four clinical trials
included in orthodontic meta-analyses [5]. Moreover, the
spotlight has been placed on deficient conduct and report-
ing of biomedical research in the recent years [6]. In
addition, meta-epidemiological research in orthodontics
has indicated that inadequate randomization procedures,
blinding and handling of missing data are pervasive within
clinical trials [7].
However, in view of the marketing of orthodontic
products and the lack of need for clinical evidence prior to
advertisement and clinical adoption of novel orthodontic
products, a further potential problem is the costly and
avoidable focus of orthodontic trials on the evaluation of
established, marketed products. This study therefore aims
to assess the prevalence of clinical trials in orthodontics
evaluating commercially marketed products. A further aim
is to evaluate the direction of the results of these studies
and whether these are affected by industry sponsorship.
Methods
Electronic searching of a single database (PubMed) was
undertaken in 15th February 2017. The term “orthodon-
tics” was searched using PubMed filters. All English
language randomized controlled trials (RCTs) in ortho-
dontics over a 5-year period (1 January 2012 to 31
December 2016) were considered for inclusion. Based
on the Cochrane criteria for the selection of RCTs,
studies were screened for eligibility using the following
eligibility criteria: human participants, interventions re-
lated to healthcare, experimental studies, presence of a
control group and randomization of participants to con-
trol and treatment groups. Studies described in the title
or abstract as “prospective”, “comparative”, or “efficacy”
were further analysed to determine if randomization of
participants was undertaken. Conference abstracts and
laboratory-based randomized trials involving extracted
human teeth were excluded. A single author (JS) screened
potentially relevant articles.All data were extracted using a pre-specified data collec-
tion sheet with specific coding of items. Data obtained
from each study included the date of publication, journal,
region of authorship (1 = Europe, 2 = America, 3 = other),
number of authors, type and justification of marketed
intervention, direction of intervention effect (1 = positive
effect compared to control, 2 = negative effect compared
to control, 3 = no difference detected between interven-
tions or between intervention and untreated control) and
declaration of both any industry sponsorship (1 = in-
dustry funded and declared, 2 = no industry sponsor-
ship to declare, 3 = not clearly declared) and conflict of
interest (1 = conflicts exist and declared, 2 = no conflicts
to declare, 3 = not clearly declared).
Statistical analysis
Descriptive statistics including means were used to re-
port the study outcomes. Cross-tabulation between indi-
vidual RCTs and marketed and non-marketed products
reported direction of effect and declaration of industry
sponsorship, and conflict of interest was undertaken
using the chi-square test or Fisher’s exact t test as appro-
priate. The level of statistical significance for all tests
was pre-specified at 0.05. Statistical analyses were
performed with STATA® version 14.2 software (Stata
Corporation, College Station, TX, USA).
Results
Initial screening yielded 362 potentially relevant articles.
Based on availability of the papers and the eligibility
criteria, 278 results were excluded. In total, 84 RCTs
published in 23 scientific journals were therefore included
in this study (Fig. 1).
In terms of order of prevalence of RCTs within specific
journals, the highest percentage were published in the
American Journal of Orthodontics and Dentofacial
Orthopedics (AJO-DO) (23.8%), followed by the European
Journal of Orthodontics (EJO) (14.3%), Journal of Orthodon-
tics (JO) (10.7%) and Angle Orthodontist (AO) (10.7%)
(Table 1). The frequency of publication of RCTs per year
was 2015 (27.4%), 2013 (23.8%), 2012 (22.6%), 2014 (19.0%)
and 2016 (7.2%). The mean number of authors was 5.1 (SD
2.6, range 1–14). The majority of RCTs were conducted in
Europe (48.1%), followed by non-American and European
countries (33.3%) and American (17.9%).
Overall, 45% (38/84) of clinical trials assessed involved
analysis of marketed products after their introduction.
The remaining trials (46/84) assessed non-clinical inter-
ventions and non-marketed products such as growth
modification and removable appliances, closing loops
and archwires. Interventions to improve oral health and
to circumvent risks of treatment, such as the treatment
of post-orthodontic white spot lesions (15.8%), were
most commonly assessed, with trials also frequently
Fig. 1 Study selection flowchart
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and orthodontic auxiliaries (13.1%). The most commonly
cited justifications for the intervention under investiga-
tion were to promote treatment efficiency (33.3%), to
reduce iatrogenic effects (20.2%) and to reduce pain
experience during treatment (16.7%). In over 50% RCTs,
a positive effect of the intervention was reported. Indus-
try sponsorship of the research was declared in 9.5%
RCTs. However, in a third (33.3%) of RCTs, whether in-
dustry sponsorship was involved is not clearly stated.
The absence of a conflict of interest was clearly stated in
50%, while in 46.4%, whether a conflict of interest
existed was not outlined (Table 2). For individual RCTs,
no significant associations between the direction of the
intervention effect and both declaration of industry
sponsorship (p = 0.56) and conflict of interest (p = 0.96)
were detected. Similarly, for marketed and non-marketed
products, no significant associations for both declaration
of industry sponsorship (p = 0.44) and conflict of interest
(p = 0.28) were found.
Discussion
The present meta-epidemiological study highlights that
almost half of orthodontic trials involve clinical evalu-
ation of the relative merits of marketed products. Many
of these do not confirm the effectiveness of these
interventions, with almost 44% reporting no improve-
ment related to the product. While these findings do
not detract from the centrality of developing novel
interventions in enhancing and streamlining orthodon-
tics, it does suggest that there may be a disconnect
between the marketing and clinical outcomes. This also
highlights the potential merit in incorporating inde-
pendent clinical research earlier in the research and
development process [8].A relatively high percentage of contemporary clinical
trials (one third) focused on techniques to hasten ortho-
dontic treatment—a zeitgeist in contemporary practice.
These include both and non-surgical adjuncts with
these thus far offering limited, largely equivocal results.
Moreover, little difference in the rate of tooth move-
ment with both surgical approaches and non-surgical
approaches has been highlighted in recent systematic
reviews—the latter encompassing vibratory stimulation,
use of masticatory adjuncts and light-mediated aids [9,
10]. Despite the relatively high number of primary stud-
ies identified in the present review, these systematic
reviews have bemoaned a lack of high-quality evidence
within these areas suggesting that further research may
still be required. The onus remains, therefore, on under-
taking clinical trials with low risk of bias and focusing
on consistent and relevant outcomes [11]. Furthermore,
non-surgical adjuncts have associated cost and often
rely on patient compliance. There is also evidence that
surgical adjuncts may lead to anxiety and potentially
hamper experiences of treatment [12].
A considerable percentage of studies involved assess-
ment of interventions to reduce pain during orthodon-
tics and other harms associated with treatment. This
focus is encouraging as these outcomes are likely to
resonate both with patients and professionals with
pain known to represent a common reason for avoid-
ance and indeed abandonment of orthodontic treat-
ment [13]. Novel approaches evaluated include both
pharmacological and novel non-pharmacological agents
with increasing emphasis on the latter, although evidence
in support of a range of non-pharmacological agents,
including vibratory stimulation and masticatory ad-
juncts, in reducing subjective pain experience is
limited [14].
Table 1 Characteristics of included randomized clinical trials
(N = 84)
N %
Journal title
American Journal of Dentofacial Orthopedics (AJO-DO) 20 23.8
Angle Orthodontist (AO) 9 10.7
Australian Orthodontic Journal (AOJ) 2 2.4
Brazilian Oral Research (BOR) 1 1.2
Clinical Oral Investigations (CIO) 2 2.4
European Journal of Orthodontics (EJO) 12 14.3
European Journal of Oral Sciences (EJOS) 1 1.2
European Journal of Paedatric Dentistry (EJPD) 1 1.2
Journal of American Dental Association (JADA) 1 1.2
The Journal of Contemporary Dental Practice (JCDP) 1 1.2
Journal of Cranio-Maxillo Facial Surgery (JCMFS) 1 1.2
Journal of Clinical Periodontology 1 1.2
The Journal of Clinical Pediatric Dentistry 1 1.2
Journal of Dental Research 4 4.8
Journal of Orthodontics 9 10.6
Journal of Oral and maxillofacial Surgery 2 2.4
Journal of Orofacial Orthopedics 1 1.2
Lasers in Medical Science 2 2.4
Orthodontics and Craniofacial Research 5 5.9
Pediatric Dentistry 1 1.2
Progress in Orthodontics 5 5.9
PLoS ONE 1 1.2
Photomedicine and Laser Surgery 1 1.2
Continent
Europe 41 48.8
America 15 17.9
Non-European or American 28 33.3
Number of authors
1–3 26 30.95
4–6 41 48.80
>7 17 20.25
Table 2 Results for primary and secondary outcomes
Category N %
Type of product
Marketed products 38 45
Non-marketed products 46 55
Intervention
Orthodontic bracket 8 9.5
Orthodontic archwire 2 2.4
Removable appliance 5 5.9
Non-surgical adjunctive 12 14.1
Surgical adjunctive 4 4.8
Retention 5 5.9
Oral health 13 15.8
Orthodontic auxiliaries 11 13.1
Interceptive treatment 5 5.9
Materials 8 9.5
Growth modification 7 8.3
Medication 4 4.8
Justification of intervention
Accelerate treatment 7 8.3
Aesthetics 2 2.4
Reduce iatrogenic effects 17 20.2
Retain tooth position 5 5.9
Reduce pain 14 16.7
Improve knowledge 1 1.2
Oral health 3 3.6
Dental development 5 5.9
Treatment efficiency 28 33.3
Compliance 2 2.4
Direction of effect
Positive 46 54.8
Negative 1 1.2
No difference 37 44.0
Industry sponsorship
Industry funded and declared 8 9.5
No industry sponsorship to declare 48 57.2
Not clearly declared 28 33.3
Conflict of interest
Conflicts exist and declared 3 3.6
No conflicts to declare 42 50
Not clearly declared 39 46.4
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existing practices in terms of the licensing and mar-
keting of orthodontic devices and products into
focus. In particular, it is accepted that clinical evi-
dence evaluating the relative merits of a clinical
technique follow its introduction. As such, the li-
censing of these techniques does not hinge on the
existence of this supporting clinical data. Historic-
ally, the potential pitfalls associated with this ap-
proach were exemplified by the re-introduction ofself-ligating brackets. This was accompanied by
positive and indeed compelling marketing, which was
given credence by the findings from early non-
randomized studies [15, 16]. However, these observations
were contradicted by more robust randomized studies,
Seehra et al. Progress in Orthodontics  (2017) 18:14 Page 5 of 6which consistently failed to corroborate either the manu-
facturers’ claims or the findings from earlier research
[17, 18]. This situation is typical of differences in
research design [19] and was aggravated by the subse-
quent refinement of bracket sub-types, including
introduction of updated versions, meaning that by the
time potentially influential research was published,
obsolete products were being reported on. As such,
clinical research should be encouraged at an earlier
stage during orthodontic product development to mitigate
against this time lag and to provide a meaningful and
contemporary clinical underpinning.
There is no doubt that industry has facilitated the
refinement of orthodontic practices and experiences
with relatively recent advancements including the advent
of fully customized labial and lingual systems, as well as
very meaningful change in appliance aesthetics [20].
Many of these improvements are clear and do not ne-
cessarily require supporting evidence; however, claims in
relation to reduced treatment times and lower require-
ment for extractions, for example, both require clinical
evidence. In the absence of evidence in this respect,
advertising claims may be misleading both to clinicians
and patients, as evidenced in the medical literature
[21, 22], particularly when marketed directly to the lat-
ter. As such, it is important for both that this is sought
at an early juncture but also that advertising claims are
modified and, where necessary, moderated in response
to emerging clinic evidence. Enforcement of the latter
could certainly be undertaken in advertisements
appearing in dental publications and at dental confer-
ences. Indeed, an analysis of advertisements in ortho-
dontic journals over a 2-year period (2012–2013)
highlighted that many of the claims made are not
evidence-based with one quarter of these citing un-
published research [23]. Moreover, given the recent
emphasis on poor yield from biomedical research [6],
it is important to highlight that there is an academic
cost attached to clinical evaluation of marketed prod-
ucts after their development, with the research itself
being costly and time-consuming. In addition, this ap-
proach has the potential to stymie researchers from
themselves undertaking original research and develop-
ment, while focusing on secondary evaluation. As such,
proving the clinical effectiveness of a product or in
some cases debunking false marketing claims may have
negative implications on the overall trajectory of
orthodontic research. This is particularly important at
present in view of the high proportion of dental
research that is devoid of patient-centred outcomes,
potentially further diluting the benefit and relevance of
clinical research [24]. At a time when academic re-
search funding is constrained, funding of independent
academics by industry may therefore be encouraged tomitigate this; examples of this are beginning to emerge
[25]. Notwithstanding this, it is important that these
funded studies are undertaken and reported independ-
ently; meta-epidemiological findings from restorative
dentistry suggest that best practice is being followed in
this respect at present [26].
The present study was restricted to clinical trials, in
isolation. Moreover, relatively few clinical trials were
identified; however, we did obtain a sample over a 5-year
period. It is therefore likely representative of contempor-
ary research practice. Further analysis could be under-
taken in time; however, unless changes are made in
relation to regulatory requirements or orthodontic com-
panies make a decision to embrace independent clinical
research at an earlier stage, it is likely that the status quo
will continue to apply.
Conclusions
Overall, 45% (38/84) of orthodontic trials over the past
5 years have involved analysis of marketed products after
their introduction. Many of these have focused on tech-
niques to accelerate tooth movement and to reduce both
orthodontic pain and other side effects. The results
highlight a potential source of waste in orthodontic re-
search emanating from existing approaches to licensing
and marketing of orthodontic products.
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